Search

Philanthropists will sometimes give large sums of money to support science — but researchers have to learn how to sell themselves first.

Technological advances remove basis for government oversight of genetically modified crops.

Non-profits that support medical research are angling for a share of the proceeds and intellectual-property rights.

Clinical-trial obligations introduced into the Helsinki declaration called too onerous by some.

Researchers must now work out how to protect cell transplants from the immune systems of people with type 1 diabetes.

Despite a chequered history, olaparib is finally before the US Food and Drug Administration.

Questions about a laboratory assay are making Sirtris, a high-profile biotechnology company, the talking point of the ageing field. Heidi Ledford investigates.

Once lauded as incubators of high-tech jobs, science parks find themselves struggling in the new financial environment.

Lawmakers may be nearing agreement on how to fix the nation's crumbling patent system, reports Heidi Ledford.

Researchers who study environmental influences on cancer tend to receive a fraction of the funds available to those researching cancer cures. But career opportunities exist — and may even be expanding. Heidi Ledford reports.

The biotechnology industry is weathering the financial crisis better than some. That doesn't mean it's in great shape, reports Heidi Ledford.

To maintain profits in the face of rising development costs and slow drug pipelines, big pharmaceutical firms are trying to cut back. Heidi Ledford examines how GlaxoSmithKline has tried to adapt.

As North Carolina's Research Triangle Park nears its fiftieth birthday, Heidi Ledford investigates how research parks across the state are coping with mounting pressure from outside competition.

How many genome sequences do you need to characterize a model organism? For Drosophila, Heidi Ledford finds, a dozen is a good start.

After boosting its number of postdocs by thousands, Japan is dealing with a major researcher glut. Heidi Ledford reports.

A meta-analysis of clinical trials for the diabetes drug Avandia has hinted at possible cardiovascular risks; but how clear is the study, and how should meta-analyses be viewed against clinical trials?

Comments concerning a report by B.J. Bushman, et al. to be published in Psychological Science (Psychol. Sci. 18, 204–207; 2007). Language: en

Short-term appointments are on the rise for teachers at colleges and universities around the world. Are these 'contingent' staff being taken for a ride? Heidi Ledford reports.

Hundreds of orchid species lure their pollinators with the promise of sex, only to send them away unfulfilled. Heidi Ledford looks at how dishonesty gives them the evolutionary edge. Hundreds of orchid species use deception in order to get pollinated. The plants lure insects with a cocktail of odours that hints at sex, but only the orchids reproduce during the exchange. Heidi Ledford delves into the evolutionary intricacies of the relationship between bees and orchids, and asks, what's in it for the bee?